This electrophysiological study was undertaken to investigate the role of voltage-operated Ca2+ channels (VOCCs) in cultivated human neuroendocrine tumor (NET) cells. Patch-clamp techniques, measurements of intracellular Ca2+ ([Ca2+]i), and secretion analysis were performed using cultured human NET BON cells. Ba2+ inward currents through R-type channels (CaV2.3) were measured and identified by SNX-482 (10 nM), a novel voltage-sensitive R-type Ca2+ channel antagonist. In the presence of nifedipine (5 µM), ω-Conotoxin GVIA (100 nM) and ω-Agatoxin IVA (20 nM), R-type channel currents were also detectable. Release of Ca2+ from intracellular Ca2+ stores by intracellular application of inositol-1,4,5-trisphosphate (InsP3; 10 µM) via the patch pipette during whole-cell configuration as well as induction of capacitative Ca2+ entry (CCE), a passive maneuver to release Ca2+ from intracellular Ca2+ stores, led to an increase in [Ca2+]i. This effect could be reduced by SNX-482 (20 nM). In addition, SNX-482 (25 nM) also decreased chromogranin A (CgA) secretion, whereas ω-Conotoxin GVIA (500 nM) and nifedipine (5 µM) failed to reduce CgA secretion. We conclude that these data reveal neuronal R-type channel activity (CaV2.3), for the first time associated with CgA secretion in BON cells. Influx of Ca2+ by activation of R-type channels may lead to an increase of intracellular Ca2+, which stimulates CgA secretion. Thus, R-type channels could play an important role in certain clinical characteristics of NETs, such as the hypersecretion syndrome.
The Journal of Membrane Biology – Springer Journals
Published: Sep 19, 2003
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera